Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
Recalling Firm: SUN PHARMACEUTICAL INDUSTRIES INC
Motif du rappel / Danger
TranslatedCGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Description du produit & Identification
TranslatedCarbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
Additional Source Details
| Field | Value |
|---|---|
| City | Princeton |
| State | NJ |
| Openfda › Nui › 1 | N0000008486 |
| Openfda › Nui › 2 | N0000175751 |
| Openfda › Nui › 3 | N0000185506 |
| Openfda › Nui › 4 | N0000191266 |
| Openfda › Nui › 5 | N0000187064 |
| Openfda › Nui › 6 | N0000185507 |
| Openfda › Nui › 7 | N0000185607 |
| Openfda › Upc › 1 | 0351672405014 |
| Openfda › Upc › 2 | 0351672412418 |
| Openfda › Upc › 3 | 0351672404741 |
| Openfda › Unii | 33CM23913M |
| Openfda › Route | ORAL |
| Openfda › Rxcui › 1 | 197442 |
| Openfda › Rxcui › 2 | 199378 |
| Openfda › Rxcui › 3 | 308973 |
| Openfda › Rxcui › 4 | 308976 |
| Openfda › Rxcui › 5 | 308979 |
| Openfda › Rxcui › 6 | 402505 |
| Openfda › Rxcui › 7 | 402506 |
| Openfda › Spl id | 48fd19fc-5d5b-0d24-e063-6294a90a0aa0 |
| Openfda › Brand name | CARBAMAZEPINE |
| Openfda › Spl set id | 0526a054-3eda-49b4-b390-7d5d16e30af8 |
| Openfda › Package ndc › 1 | 51672-4041-1 |
| Openfda › Package ndc › 2 | 51672-4041-2 |
| Openfda › Package ndc › 3 | 51672-4041-9 |
| Openfda › Package ndc › 4 | 51672-4041-0 |
| Openfda › Package ndc › 5 | 51672-4050-1 |
| Openfda › Package ndc › 6 | 51672-4005-1 |
| Openfda › Package ndc › 7 | 51672-4005-2 |
| Openfda › Package ndc › 8 | 51672-4005-3 |
| Openfda › Package ndc › 9 | 51672-4123-6 |
| Openfda › Package ndc › 10 | 51672-4123-1 |
| Openfda › Package ndc › 11 | 51672-4123-3 |
| Openfda › Package ndc › 12 | 51672-4124-6 |
| Openfda › Package ndc › 13 | 51672-4124-1 |
| Openfda › Package ndc › 14 | 51672-4124-3 |
| Openfda › Package ndc › 15 | 51672-4125-6 |
| Openfda › Package ndc › 16 | 51672-4125-1 |
| Openfda › Package ndc › 17 | 51672-4125-3 |
| Openfda › Package ndc › 18 | 51672-4047-9 |
| Openfda › Package ndc › 19 | 51672-4047-4 |
| Openfda › Product ndc › 1 | 51672-4005 |
| Openfda › Product ndc › 2 | 51672-4041 |
| Openfda › Product ndc › 3 | 51672-4050 |
| Openfda › Product ndc › 4 | 51672-4123 |
| Openfda › Product ndc › 5 | 51672-4124 |
| Openfda › Product ndc › 6 | 51672-4125 |
| Openfda › Product ndc › 7 | 51672-4047 |
| Openfda › Generic name | CARBAMAZEPINE |
| Openfda › Product type | HUMAN PRESCRIPTION DRUG |
| Openfda › Pharm class pe | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| Openfda › Substance name | CARBAMAZEPINE |
| Openfda › Pharm class epc | Mood Stabilizer [EPC] |
| Openfda › Pharm class moa › 1 | Cytochrome P450 3A4 Inducers [MoA] |
| Openfda › Pharm class moa › 2 | Cytochrome P450 1A2 Inducers [MoA] |
| Openfda › Pharm class moa › 3 | Cytochrome P450 2B6 Inducers [MoA] |
| Openfda › Pharm class moa › 4 | Cytochrome P450 2C9 Inducers [MoA] |
| Openfda › Pharm class moa › 5 | Cytochrome P450 2C19 Inducers [MoA] |
| Openfda › Manufacturer name | Sun Pharmaceutical Industries, Inc. |
| Openfda › Application number | ANDA074649 |
| Openfda › Is original packager | true |
| Event id | 99562 |
| Address 1 | 2 Independence Way |
| Code info | Lot # AD94033, Exp Date: 5/31/2028. |
| Postal code | 08540-6620 |
| Report date | 20260826 |
| Product type | Drugs |
| Product quantity | 1968 Bottles (1000Tablets/Bottle) |
| Reason for recall | CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing |
| Voluntary mandated | Voluntary: Firm initiated |
| Recall initiation date | 20260803 |
| Initial firm notification | Letter |
| Center classification date | 20260818 |
Consumer Action Protocol: What You Should Do Immediately
Safety StepsInspect the NDC code, batch number, or control number on your medicine bottle or blister packaging to confirm whether your unit is included.
Do not abruptly stop critical prescribed medication without physician advice. Contact your dispensing pharmacist immediately for a safe alternative.
Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.
If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (FDA Drugs).
Your Legal Rights as a Consumer
Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.
Frequently Asked Questions About This Recall
FAQ GuideQ1:What should I do immediately if I own or bought Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd.,...?
Check the lot number and NDC on your prescription label. For essential medications, consult your doctor or dispensing pharmacist immediately before abruptly stopping your dose.
Q2:Can I get a full refund or free repair for this recall?
Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.
Q3:Do I need my original sales receipt to claim a remedy or refund?
In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.
Q4:Where can I verify official information for this safety alert?
This safety alert is aggregated directly from official regulatory agency records (FDA Drugs). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.
Vérifiez les autres produits de votre foyer
Outils gratuitsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Aperçu
- Entreprise responsableSUN PHARMACEUTICAL INDUSTRIES INC
- StatusOngoing
- Niveau de risqueClass II
- DistributionUS Nationwide.
📢 Partager l’alerte
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: SUN PHARMACEUTICAL INDUSTRIES INC - Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3. Check if your household is affected: https://therecallfile.com/fr/recalls/carbamazepine-tablets-usp-200mg-1000-count-bottles-rx-only-manufacture/FDA-D-0770-2026
Rejoindre la liste d’alerte
Recevez des alertes e-mail instantanées dès qu’un rappel critique est publié.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.